James L. Mohler, MD, on Prostate Cancer: Updated NCCN Recommendations

Posted: Thursday, June 28, 2018

James L. Mohler, MD, of Roswell Park Cancer Institute and Chair of the NCCN Panel on Prostate Cancer, discusses recent updates to NCCN recommendations pertaining to prostate cancer, personalized medicine, molecular risk stratification, and better androgen-deprivation therapy for men with prostate cancer.